Literature DB >> 11458275

DNA ploidy analyses in 218 consecutive Pakistani breast cancer patients: does it add anything?

E Khan1, Z Mapara, S Khan, N Arshad, T Siddiqui, S Pervez.   

Abstract

An analysis was made to evaluate the significance of DNA ploidy in the biology and prognosis of breast carcinoma. This was done by estimating the correlation of DNA ploidy with other established prognostic markers of breast cancer, namely tumor size, tumor grade, lymph node metastasis and S-phase fraction. From 1995 up to year 2000 ploidy analysis was performed on 218 consecutive cases of infiltrating breast carcinoma by flow cytometry using formalin fixed paraffin embedded material. From the laboratory record, data regarding other pathological variables was retrieved. No correlation could be found between DNA ploidy and tumor grade, nor could there be found a correlation with tumor size. For lymph node metastasis there was a significant difference between the proportion of aneuploids and diploids having metastasis in more than 4 lymph nodes. However, no significant difference was found in axillary lymph node positive and negative groups when number of positive lymph nodes was not taken into account. The mean value of S-phase fraction for the aneuploids and the diploids was also insignificantly different. In conclusion DNA ploidy alone did not add much to predict tumor behaviour in terms of known pathologic variables.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11458275     DOI: 10.1007/BF03032578

Source DB:  PubMed          Journal:  Pathol Oncol Res        ISSN: 1219-4956            Impact factor:   3.201


  21 in total

1.  [Relationship between DNA ploidy and survival in breast cancer].

Authors:  Y Utada; M Yoshimoto; F Kasumi; F Akiyama; G Sakamoto
Journal:  Gan To Kagaku Ryoho       Date:  1998-04

2.  The value of S-phase and DNA ploidy analysis as prognostic markers for node-negative breast cancer in the Australian setting.

Authors:  S W Wong; A M Rangan; A M Bilous; J Boyages; V Gebski; E M Benson
Journal:  Pathology       Date:  1999-05       Impact factor: 5.306

3.  Analysis of prognostic factors in Chinese women with breast cancer in southern Taiwan.

Authors:  C M Chen; H T Chang; K T Mok; C I Liu; C C Tsai; N W Jou; B W Wang; I S Chen
Journal:  Zhonghua Yi Xue Za Zhi (Taipei)       Date:  1999-10

4.  Relationships of DNA ploidy, S-phase fraction and hormone receptor status to tumor stage in breast cancers detected by population screening. The South-East Sweden Breast Cancer Group.

Authors:  O Stål; A Brisfors; J Carstensen; L Ferraud; T Hatschek; B Nordenskjöld
Journal:  Int J Cancer       Date:  1992-04-22       Impact factor: 7.396

5.  Flow-cytometric DNA analysis in primary breast carcinomas and clinicopathological correlations.

Authors:  S B Ewers; E Långström; B Baldetorp; D Killander
Journal:  Cytometry       Date:  1984-07

6.  Correlation of DNA flow cytometric results and other prognostic factors in primary breast cancer.

Authors:  G E Feichter; A Mueller; M Kaufmann; D Haag; I A Born; U Abel; K Klinga; F Kubli; K Goerttler
Journal:  Int J Cancer       Date:  1988-06-15       Impact factor: 7.396

7.  The relationship between flow-cytometric and immunohistochemically detected c-erbB-2 expression, grade and DNA ploidy in breast cancer.

Authors:  I Brotherick; B K Shenton; W K Cowan; B Angus; C H Horne; M J Higgs; T W Lennard
Journal:  Cancer Immunol Immunother       Date:  1995-09       Impact factor: 6.968

8.  Prognostic significance of DNA-ploidy in a series of 690 primary breast cancer patients.

Authors:  H Beerman; P M Kluin; J Hermans; C J van de Velde; C J Cornelisse
Journal:  Int J Cancer       Date:  1990-01-15       Impact factor: 7.396

9.  DNA ploidy, S-phase, and steroid receptors in more than 127,000 breast cancer patients.

Authors:  C R Wenger; S Beardslee; M A Owens; G Pounds; T Oldaker; P Vendely; M R Pandian; D Harrington; G M Clark; W L McGuire
Journal:  Breast Cancer Res Treat       Date:  1993-10       Impact factor: 4.872

10.  The prognostic significance of DNA flow cytometry in breast cancer: results from 881 patients treated in a single centre.

Authors:  R S Camplejohn; C M Ash; C E Gillett; B Raikundalia; D M Barnes; W M Gregory; M A Richards; R R Millis
Journal:  Br J Cancer       Date:  1995-01       Impact factor: 7.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.